Delayed pressure urticaria: Clinical features, laboratory investigations, and response to therapy of 44 patients†
References (30)
- et al.
Delayed pressure urticaria
J Allergy Clin Immunol
(1982) - et al.
Delayed pressure urticaria: an investigation of some parameters of lesion induction
J Am Acad Dermatol
(1981) - et al.
Morphology of the cellular infiltrate in delayed pressure urticaria
J Am Acad Dermatol
(1985) - et al.
Assessment of tissue fluid histamine levels in patients with urticaria
J Allergy Clin Immunol
(1978) - et al.
Extracellular deposition of eosinophil major basic protein in pressure urticaria
J Am Acad Dermatol
(1987) - et al.
Factitious whealing at the site of a previous cutaneous response
Br J Dermatol
(1969) - et al.
Symptomatic dermographism: natural history, clinical features, laboratory investigations and response to therapy
Clin Exp Dermatol
(1983) - et al.
Urticaria
- et al.
Tests to establish the diagnosis of cholinergic urticaria
Br J Dermatol
(1978) - et al.
Protease inhibitor profiles in urticaria and antioedema
Br J Dermatol
(1980)
Urticaria and angioedema: a review of 554 patients
Br J Dermatol
Delayed pressure urticaria
Br J Dermatol
Protease inhibitors in plasma of patients with chronic urticaria
Arch Dermatol
Physical urticaria: Its diagnosis and treatment
Incidence of atopy in the general population
Arch Dermatol
Cited by (86)
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics
2023, Journal of Allergy and Clinical Immunology: In PracticePhysical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management
2023, Journal of the American Academy of DermatologyDelayed Pressure Urticaria: A Systematic Review of Treatment Options
2020, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Swerlick and Puar37 showed that sulfasalazine treatment resulted in complete, near-complete, or partial response in 15 of 17 patients (88.2%) on the basis of reduction in DPU symptoms and the ability of patients to return to normal activities. Dover et al9 showed that indomethacin was not more effective than placebo for reducing the size of DPU lesions or improving symptoms. Lawlor et al6 reported no significant differences in the number or size of DPU lesions in patients treated with colchicine or placebo.
Recalcitrant, delayed pressure urticaria treated with long-term intravenous immunoglobulin
2020, JAAD Case ReportsThe diagnosis and management of acute and chronic urticaria: 2014 update
2014, Journal of Allergy and Clinical ImmunologyContemporary approaches to the diagnosis and management of physical urticaria
2013, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Short courses of oral corticosteroids may be required, but long-term use of oral corticosteroids is not recommended. Some cases of DPUA may benefit from nonsteroidal anti-inflammatory drugs, but no statistically significant benefit was found in a double-blinded trial with indomethacin 25 mg 3 times a day compared with placebo.30,32 Because many patients with physical urticaria also have spontaneous CU outbreaks, which may be exacerbated by the administration of cyclooxygenase-1–inhibiting drugs, prescribing aspirin or aspirin-like drugs to patients with DPUA should be approached cautiously.82
- †
Presented in part at the meeting of the British Association of Dermatologists, Sheffield, England, July 11, 1986.
- *
From St. John's Hospital for Diseases of the Skin and The Dermatology Institute, London
- **
Protein Reference Laboratory, Hallamshire Hospital Medical School, Sheffield.